{"doi":"10.4049/jimmunol.165.6.3080","title":"Critical Relationship Between TCR Signaling Potential and TCR Affinity During Thymocyte Selection","abstract":"<jats:title>Abstract</jats:title>\n                  <jats:p>Whether a developing thymocyte becomes positively or negatively selected is thought to be determined by the affinity/avidity of its TCR for MHC/peptide ligands expressed in the thymus. Presumably, differences in affinity translate into differences in the potency of the ensuing TCR-mediated signals, and these differences in signal strength determine the outcome of thymocyte selection. However, there is little direct evidence establishing a relationship between TCR-ligand affinity and signal strength during positive and negative selection. The TCR complex contains multiple signaling motifs, known as immunoreceptor tyrosine-based activation motifs (ITAMs) that are required for T cell activation. To examine the effects of TCR signal strength on selection, the signaling potential of the TCR was modified by substituting transgenic TCR ζ-chains containing either three, one, or zero ITAMs for endogenous (3-ITAM) ζ-chain. These ζ-chain variants were then bred into different αβTCR transgenic backgrounds. We report that reductions in TCR signaling potential have distinct effects on the selection of thymocytes expressing different TCRs, and that the requirement for ζ-chain ITAMs critically depends upon the specificity and apparently, affinity, of the TCR for its selecting ligand(s).</jats:p>","journal":"The Journal of Immunology","year":2000,"id":609415,"datarank":0.6307038929086449,"base_score":4.204692619390966,"endowment":4.204692619390966,"self_citation_contribution":0.6307038929086449,"citation_network_contribution":0.0,"self_endowment_contribution":0.6307038929086449,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":66,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":737454,"name":"Jan Lee","orcid":"0000-0002-7393-2533","position":1,"is_corresponding":false},{"id":1566356,"name":"Elizabeth W Shores","orcid":null,"position":2,"is_corresponding":false},{"id":1566354,"name":"Paul E Love","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Critical Relationship Between TCR Signaling Potential and TCR Affinity During Thymocyte Selection","abstract":"<jats:title>Abstract</jats:title>\n                  <jats:p>Whether a developing thymocyte becomes positively or negatively selected is thought to be determined by the affinity/avidity of its TCR for MHC/peptide ligands expressed in the thymus. Presumably, differences in affinity translate into differences in the potency of the ensuing TCR-mediated signals, and these differences in signal strength determine the outcome of thymocyte selection. However, there is little direct evidence establishing a relationship between TCR-ligand affinity and signal strength during positive and negative selection. The TCR complex contains multiple signaling motifs, known as immunoreceptor tyrosine-based activation motifs (ITAMs) that are required for T cell activation. To examine the effects of TCR signal strength on selection, the signaling potential of the TCR was modified by substituting transgenic TCR ζ-chains containing either three, one, or zero ITAMs for endogenous (3-ITAM) ζ-chain. These ζ-chain variants were then bred into different αβTCR transgenic backgrounds. We report that reductions in TCR signaling potential have distinct effects on the selection of thymocytes expressing different TCRs, and that the requirement for ζ-chain ITAMs critically depends upon the specificity and apparently, affinity, of the TCR for its selecting ligand(s).</jats:p>","is_dataset_classified":null,"base_score":4.204692619390966,"endowment":4.204692619390966,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"10975819","pmcid":null,"openalex_id":"https://openalex.org/W1516792321","authors":[],"funders":[],"total_grants":0,"fwci":2.4422,"citation_percentile":0.88863726,"influential_citations":0,"citation_trend":[{"year":2012,"count":1},{"year":2013,"count":3},{"year":2014,"count":1},{"year":2015,"count":3},{"year":2018,"count":1},{"year":2019,"count":1},{"year":2022,"count":1},{"year":2025,"count":3}],"oa_status":"bronze","license":"https://academic.oup.com/pages/standard-publication-reuse-rights","oa_locations":[{"url":"https://journals.aai.org/jimmunol/article-pdf/165/6/3080/1125010/3080.pdf","host_type":"journal"},{"url":"https://journals.aai.org/jimmunol/article-pdf/165/6/3080/1125010/3080.pdf","host_type":"publisher"},{"url":"https://academic.oup.com/jimmunol/article-pdf/165/6/3080/62135344/3080.pdf","host_type":"publisher"},{"url":"https://doi.org/10.4049/jimmunol.165.6.3080","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/10975819","host_type":"repository"}],"fields_of_study":["T-cell and B-cell Immunology","Immune Cell Function and Interaction","Immunotherapy and Immune Responses"],"mesh_terms":["CD69 Antigens","Animals","Antigens, Differentiation, T-Lymphocyte","Histocompatibility Antigens Class II","Cell Differentiation","Female","Ligands","Mice, Transgenic","Protein Binding","Receptors, Antigen, T-Cell","Receptors, Immunologic","T-Lymphocytes","Thymus Gland","Signal Transduction","Antigens, CD","CD4 Antigens","Receptors, Antigen, T-Cell, alpha-beta","Lymphocyte Count","Epitopes, T-Lymphocyte","Transgenes","Lectins, C-Type","Mice"],"keywords":["T-cell receptor","Immunoreceptor tyrosine-based activation motif","Avidity","Negative selection","Biology","Thymocyte","Transgene","Cell biology","Immunology","T cell","CD8","Genetics","Antigen","Gene","Immune system"],"sdg_mappings":[],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-07-31T07:38:58.415758Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}